Externally Sponsored Research supports independent researchers and external sponsors studying Gilead products or therapeutic areas to expand medical knowledge, inform care and improve patients’ lives.
Gilead removed the Hepatitis B and Hepatitis C Topics of Interest, both previously accepting concepts on a rolling basis until funds were exhausted. The removed topics covered updated HBV treatment guidelines and shared decision-making, and coordinated care and treatment for HCV-positive pregnant patients.
Gilead Sciences' Corporate Sponsorships fund nonprofit events advancing research and education in HIV, liver disease, oncology, and chronic inflammatory diseases.
Gilead Sciences' Research Scholars Program funds innovative research by emerging investigators in HIV, viral hepatitis, primary biliary cholangitis, and oncology, with a focus on diversity and scientific advancement.
Gilead Sciences Sponsorships fund nonprofit-led events and initiatives that advance awareness, education, and engagement in HIV, liver disease, and oncology.
Non-Accredited Medical and Scientific Grant Funding supports medical educators' independent education and scientific exchange to advance healthcare professionals' knowledge and improve patient care.
Gilead Sciences Corporate Grants support nonprofit-led research and scientific projects aligned with Gilead’s therapeutic focus areas and mission, emphasizing compliance, transparency, and ethical standards.